20 likes | 115 Views
This study by Dragu et al. (2006) explores the impact of reperfusion therapies on 30-day crude mortality in patients with ST-elevation myocardial infarction (STEMI) and renal failure. Findings may guide treatment decisions in this high-risk population.
E N D
ACSIS: Reperfusion therapies in patients with STEAMI and renal failure Dragu R et al. Am J Cardiol 2006; 97:1142-1145.
30-day crude mortality by reperfusion strategy Dragu R et al. Am J Cardiol 2006; 97:1142-1145.